Altered gene expression by cisplatin in a human squamous cell lung carcinoma cell line
Yatomi, M.; Takiguchi, Y.; Asaka-Amano, Y.; Arai, M.; Tada, Y.; Kurosu, K.; Sakao, S.; Kasahara, Y.; Tanabe, N.; Tatsumi, K.; Seki, N.; Kuriyama, T.
Anticancer Research 27(5a): 3235-3243
2007
ISSN/ISBN: 0250-7005 PMID: 17970066 Document Number: 613936
Background: Substantial evidence has disclosed that some cytotoxic agents have complex activities in influencing signal transduction pathways in cells. Materials and Methods: cDNA microarray analysis was performed after exposing a human squamous cell carcinoma cell line, RERF-LC-AI, to low-dose cisplatin for 5 days. Up-regulated gene expressions were suppressed by small interfering RNA to investigate phenotypic alteration of the cells. Results: Among 30, 000 genes screened, 42 genes showed increases or decreases in expression of more than 2-fold with cisplatin treatment. They included genes with functions involved in apoptosis, cell cycle regulation and DNA metabolism/repair. Suppression of the 5 most significantly altered genes by small interfering RNA resulted in partly reduced apoptosis without altering cytotoxicity of cisplatin. Conclusion: Besides direct cytotoxic effects on cells, cisplatin may have indirect effects involving drug resistance, and synergistic effects with other agents.